GLP-2 10mg
LOT MOL-101
99.71%
HPLC purity · meets spec
- Labeled
- 10mg
- Measured
- 10.34mg
- Identity
- Confirmed
- Tested
- Aug 7, 2026
3 assays passed · ISO/IEC 17025 accredited
View certificate
GLP-2 | Peptide Vials
10mg
$36.00
Regular price
$54.00
Sale price
$36.00
Skip to product information
GLP-2 | Peptide Vials
$36.00
Regular price
$54.00
Sale price
$36.00
Type
Bundle & save
Price
$36.00
For research use only. Not for human consumption. Compassionate curators of fine peptides.
GLP-2 · 10mg
Mollecule GLP-2 is manufactured for researchers seeking premium-quality peptide materials supported by verified laboratory testing. Comparable to the active ingredient in Tirzepatide. As one of the most recognized peptides in metabolic research, it continues to play an important role in advancing scientific understanding of peptide biology. Every production lot is independently tested by accredited third-party laboratories, with Certificates of Analysis (COAs) available to confirm purity, identity, and manufacturing consistency.
Pack
5mg Peptide Vials: $36.00
10mg Peptide Vials: $36.00
20mg Peptide Vials: $59.00
30mg Peptide Vials: $75.00
Also available: GLP-2 | 5ct Peptide Strips
Related peptides
Third-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch’s certificate below.
Sources & References
Peer-reviewed research
-
NEW ENGLAND JOURNAL OF MEDICINE
Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial
View Source -
THE LANCET
GLP-3 (RT) for People with Type 2 Diabetes - A Phase 2 Trial
View Source -
NATURE MEDICINE
GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease
View Source -
LANCET DIABETES & ENDOCRINOLOGY
Effects of GLP-3 (RT) on Body Composition
View Source -
PUBMED CENTRAL
Triple Agonism Based Therapies for Obesity
View Source -
PUBMED CENTRAL
GLP-3 (RT) - A Game Changer in Obesity Pharmacotherapy
View Source -
PUBMED CENTRAL
Efficacy and Safety of GLP-3 (RT) - Systematic Review & Meta-Analysis
View Source -
ELI LILLY
TRIUMPH-4 Phase 3 Trial Results
View Source -
NATURE CELL DISCOVERY
Structural Analysis of Incretin Receptor Agonists
View Source -
PUBCHEM DATABASE
GLP-3 (RT) Compound Information
View Source -
CLINICALTRIALS.GOV
GLP-3 (RT) Clinical Trials Registry
View Source